03/17/2023

Madaline Spencer

March 17, 2023

Executive Summary

Arthur Suckow, Ph.D., chief executive officer at DTx Pharma talks about Charcot-Marie-Tooth Disease Type 1A (CMT1A) and a treatment in development for this rare disease.

Read Full Article